Prevention of insulin-dependent diabetes mellitus 1998.
Recent advances in the understanding of the pathogenesis of insulin-dependent diabetes mellitus (IDDM) have led to the first trials of disease prevention in susceptible individuals. Two main trials (nicotinamide and insulin) are now running but first results will not be available before the turn of the century. Pilot trials using different approaches, most of them based on the induction of immunotolerance, are also under way and should offer new insight for establishing larger multicentre studies including attempts aimed at primary prevention by removal of diabetogenic components in cow's milk. The field is moving fast and it is expected that intervention for IDDM prevention will be offered to an increasing number of individuals found at risk of developing the disease.
Pozzilli
P
P
Libero Istituto Universitario, Campus Biomedico, Rome, Italy.
D002986:Clinical Trials as Topic; D003922:Diabetes Mellitus, Type 1 / Q000517:prevention & control*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D009536:Niacinamide / Q000627:therapeutic use
D007004:Hypoglycemic Agents; D007328:Insulin; D009536:Niacinamide